ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,167
0,44%
Bitcoin
68.928,90
1,48%
Brent Oil
81,965
0,81%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sirna Therapeutics (RNAI)

  7. Sirna Therapeutics (RNAI) Notícias

RNAI

Sirna Therapeutics (RNAI)

Sirna Therapeutics
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RNAI
DataHoraFonteTítuloCódigoCompanhia
03/01/200811:00MarketwiredBoston-Power(R) Fuels Next Stage of Growth With One of the Largest Portable Power Venture InvestmentsNASDAQ:RNAISirna Therapeutics
28/12/200618:00PR Newswire (US)Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.NASDAQ:RNAISirna Therapeutics
14/12/200611:38Business WireMerck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of SirnaNASDAQ:RNAISirna Therapeutics
13/11/200619:36PR Newswire (US)Sirna Therapeutics Reports Third Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
30/10/200618:35Business WireMerck & Co., Inc. to Acquire Sirna Therapeutics, Inc.NASDAQ:RNAISirna Therapeutics
11/10/200611:00PR Newswire (US)Sirna Therapeutics to Present at 2006 BIO InvestorForumNASDAQ:RNAISirna Therapeutics
18/09/200616:19PR Newswire (US)Sirna Therapeutics to Present at UBS Global Life Sciences ConferenceNASDAQ:RNAISirna Therapeutics
08/09/200617:00PR Newswire (US)Sirna Therapeutics to Present at BioJapan 2006 World Business ForumNASDAQ:RNAISirna Therapeutics
31/08/200618:30PR Newswire (US)Sirna Therapeutics to Present at Two Upcoming ConferencesNASDAQ:RNAISirna Therapeutics
14/08/200618:04PR Newswire (US)Sirna Therapeutics Reports Second Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
10/08/200610:19PR Newswire (US)Sirna Therapeutics Reports Final Results from Phase 1 Study on Its RNAi-Based Therapeutic for Age-Related Macular DegenerationNASDAQ:RNAISirna Therapeutics
07/08/200619:25PR Newswire (US)Sirna Therapeutics to Report Second Quarter 2006 Financial Results on August 14, 2006NASDAQ:RNAISirna Therapeutics
03/08/200610:07PR Newswire (US)Sirna Therapeutics to Present at Bank of America 2006 Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
06/07/200610:11PR Newswire (US)Sirna Therapeutics Joins Russell 3000 IndexNASDAQ:RNAISirna Therapeutics
05/07/200610:11PR Newswire (US)Sirna Therapeutics to Present at the C.E. Unterberg, Towbin Emerging Growth ConferenceNASDAQ:RNAISirna Therapeutics
23/06/200610:26PR Newswire (US)European Patent Office Significantly Limits Scope of Kreutzer-Limmer RNAi Patent ClaimNASDAQ:RNAISirna Therapeutics
08/06/200610:00PR Newswire (US)Sirna Therapeutics to Webcast Presentation at the Needham & Company Biotechnology and Medical Technology ConferenceNASDAQ:RNAISirna Therapeutics
30/05/200609:03PR Newswire (US)Sirna Therapeutics Announces Exercise of Over-Allotment Option By UnderwritersNASDAQ:RNAISirna Therapeutics
24/05/200608:14PR Newswire (US)Sirna Therapeutics Announces Pricing of Common Stock OfferingNASDAQ:RNAISirna Therapeutics
15/05/200608:13PR Newswire (US)Sirna Therapeutics Announces Public Offering of Common StockNASDAQ:RNAISirna Therapeutics
10/05/200610:20PR Newswire (US)Sirna Therapeutics Licenses Worldwide Exclusive Rights to microRNA Technology from University of Massachusetts Medical SchoolNASDAQ:RNAISirna Therapeutics
04/05/200609:36PR Newswire (US)Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKlineNASDAQ:RNAISirna Therapeutics
02/05/200609:36PR Newswire (US)Sirna Therapeutics Reports First Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
26/04/200609:08PR Newswire (US)Sirna Therapeutics to Report First Quarter 2006 Financial Results on May 2, 2006NASDAQ:RNAISirna Therapeutics
20/04/200609:02PR Newswire (US)Sirna Therapeutics to Webcast Presentation at the UBS Global Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
03/04/200610:38PR Newswire (US)Sirna Therapeutics Granted First Broad siRNA Patent for a Gene Target in the United StatesNASDAQ:RNAISirna Therapeutics
03/04/200610:32PR Newswire (US)GlaxoSmithKline and Sirna Therapeutics Announce Major Alliance in RNAi-Based Therapeutics for Respiratory DiseaseNASDAQ:RNAISirna Therapeutics
28/03/200621:45PR Newswire (US)Sirna Therapeutics to Webcast Presentation at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
14/03/200610:37PR Newswire (US)Sirna Therapeutics Announces Its Scientific Advisory BoardNASDAQ:RNAISirna Therapeutics
01/03/200618:01PR Newswire (US)Sirna Therapeutics Reports Fourth Quarter and Year End 2005 Financial ResultsNASDAQ:RNAISirna Therapeutics
 Apresentando as notícias mais relevantes sobre:NASDAQ:RNAI

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
RNEW4
RENOVA PN
BOV
PRIO3
PETRORIO ON
BOV
AMER3
Americanas ON
BOV
AZEV4
AZEVEDO PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
GOLL4
GOL PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
SGPS3
SPRINGS ON
BOV
COGN3
COGNA ON
BOV
TELB4
TELEBRAS PN
BOV
RPMG3
PET MANGUINH ON
BOV
HAGA3
HAGA ON
BOV
CLSA3
Clear Sale ON
BOV
GFSA3
GAFISA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados